Ushering in the New Year, Looking Back at 2019
We hope everybody is settling into the New Year. Here’s a look back at what happened in 2019. Brexanolone takes the lead as our top story for 2019. Brexanolone (introduced as SAGE-547 by SAGE Therapeutics) is a neurosteroid, an analogue of allopregnanolone, which is a novel type of antidepressant, acting as an allosteric modulator of… Read More »